Innovation In Phase 1 Clinical Development
|Event Date/Time: Sep 17, 2012||End Date/Time: Sep 19, 2012|
-Hear the latest regulatory perspective on acceptable protocol design from MHRA
-Learn from, meet and engage with the most senior early development speaker panel in Europe â€“ 70% are Director/VP/C-level
-Join the Licensing Network! Shrinking budgets and drying pipelines have spurred an increase in licensing activity in the clinical community, join the network to find your perfect partner!
-Drive innovation and drug development through collaborations with academia and adopting alternative partnership models
-Overcome the challenges of biomarker development and realise their full potential in patient stratification